genedrive plc, the near patient molecular diagnostics company, has announced that it has entered into a distribution agreement with Beckman Coulter Life Sciences (“Beckman Coulter”) for its Genedrive® 96 SARS-CoV-2 Kit. The agreement enables Beckman Coulter to sell and distribute genedrive’s high-throughput COVID-19 PCR Kit in the United States and Europe for use on upper respiratory … Continued
Surrey-based Ashford and St Peter’s Hospitals NHS Foundation Trust, one of the UK’s foremost Trusts, is piloting a demand-led rostering solution with Rotageek and Locum’s Nest, who create software connecting healthcare professionals to flexible work. Together they will test the NHS’ first-of-its-kind demand-led rostering. The solution links scheduling and locums in an integrated network that … Continued
Richard Moore – Co head of Investments 2020 impacted businesses both large and small. Covid-19 and government mandated lockdowns created a very uncertain economic outlook and companies across the board took measures to strengthen balance sheets and preserve cash. The impacts were not felt equally and sectors such as consumer, leisure and retail were hit … Continued
Oxford BioTherapeutics Ltd., a clinical stage oncology company with a pipeline of immuno-oncology (IO) and antibody-drug conjugate (ADC)-based therapies and Kite, a Gilead Company, have announced that they have entered into a research collaboration to evaluate five novel targets for a number of hematologic and solid tumor indications. Through this collaboration, OBT will validate five … Continued
Arecor has announced that partner Inhibrx Inc. is to license a novel enhanced formulation of its proprietary therapeutic candidate, INBRX-101, developed by Arecor using the Company’s patented technology, Arestat™. This is the first license under a multi-product development agreement between two companies with the new formulation developed using Arestat, Arecor’s patented reformulation platform. INBRX-101 is a treatment for … Continued
Welcome to our final quarterly update of 2020. All of us will always remember 2020. It has disrupted daily lives and impacted businesses big and small. In many ways, the way we live and the ways in which businesses operate will be different going forward. Overall, our portfolio ends the year in robust shape. We … Continued
C4X Discovery Holdings plc, a pioneering Drug Discovery company, confirms that Clive Dix, Chief Executive Officer of C4XD has stepped into the role of Interim Chair of the UK Vaccine Taskforce, the group set up by the Government to lead UK efforts to find and manufacture a COVID-19 vaccine. The Government will set out arrangements … Continued
Earlier this year Wonderhood was appointed the creative account to Branston owner Mizkan. They have released their first TV advert for Branston, to critical acclaim. Campaign called the ad “heartwarming” when awarding it the ‘Ad of the Day.’ Little Black book commented it “evoked powerful memories of home” and ‘David Reviews’ gave the ad five … Continued
Streaming giant ups budget by 50% as Disney also invests in production facilities at Pinewood Studios Netflix will boost its spend on making TV shows in the UK to $1bn (£750m) this year as the streaming giant maintains the breakneck pace of its production pipeline despite the coronavirus pandemic. Netflix, which makes shows such as The … Continued
At a time when the pandemic has challenged so many established business models, entertainment, predominantly home entertainment, is one of the few sectors continuing to grow and the screen industry is one of the fastest growing sectors in the UK. John Glencross, Chief Executive of Calculus Capital, which launched the Calculus Creative Content EIS Fund … Continued